ENDONOVO THERAPEUTICS, INC. Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDONOVO THERAPEUTICS, INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2021-09-30 was 0.00 shares.
- ENDONOVO THERAPEUTICS, INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2021-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2021-03-31 was 3.01M shares, a 3022.00% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. shares issued, shares, share-based payment arrangement, after forfeiture for the quarter ending 2020-09-30 was 0.00 shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture 12 month |
|---|---|---|
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | |
| 2021-03-31 | 3.01M shares 10-Q · filed 2021-05-24 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | |
| 2020-06-30 | 1.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | |
| 2020-03-31 | 96.53K shares 10-Q · filed 2021-05-24 |